Podiatrist · Coral Gables, FL
NPI
1740547520
Since 2012
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3146 Coral Way
Coral Gables, FL, 33145
Phone (786) 536-9656
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$178K
7,809 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Marien R Kelly prescribed most often to Medicare patients was Ammonium Lactate, with 2,856 prescriptions and refills. In total Marien R Kelly wrote 7,809 Medicare prescriptions that cost $178K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ammonium Lactate Generic | 2,856 | 3,197 | 938 | $61K |
| Ketoconazole Generic | 1,106 | 1,199 | 426 | $17K |
| Ciclopirox Generic | 951 | 1,099 | 348 | $40K |
| Ciclopirox Ciclopirox Olamine | 933 | 979 | 321 | $15K |
| Mupirocin Generic | 728 | 776 | 359 | $4,152 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 247 | 270 | 114 | $3,883 |
| Diclofenac Sodium Generic | 238 | 291 | 143 | $5,189 |
| Gentamicin Sulfate Generic | 237 | 246 | 111 | $10K |
| Nystatin Generic | 144 | 158 | 57 | $1,865 |
| Doxycycline Hyclate Generic | 110 | 110 | 88 | $859 |
| Econazole Nitrate Generic | 66 | 68 | 21 | $1,681 |
| Triamcinolone Acetonide Generic | 27 | 27 | 16 | $95.13 |
| Silver Sulfadiazine Generic | 23 | 24 | 18 | $293 |
| Tavaborole Generic | 16 | 16 | Under 11 | $15K |
| Meloxicam Generic | 14 | 14 | 14 | $6.38 |
Brand drugs: 37 claims; generic drugs: 7,772 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marien R Kelly were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.